Tag Archives: Affitech

Promising future for r84

Dr. Martin Welschof is a co-founder and Managing Director of Affitech A/S. Affitech laboratories are in the Oslo Research Park. (Photo courtesy of Affitech)

Affitech tests exciting new anti-cancer drug candidate John Erik Stacy, 22 Feb 2011 Affitech has an exciting anti-cancer drug candidate, now known simply as r84, shown to fight cancer growth in animal trials. Like Avastin (Genentech), Herceptin (Roche), Erbitux (Merck) and other new anticancer drugs, r84 is a monoclonal antibody. This type of drug continues to be ...

Affitech stands for cancer-drug discovery at Oslo Research Park


Affitech developes R84 in partnership with US Peregrine Pharmaceutical John Erik Stacy Affitech is one of the hot new biotech companies to be hatched out of the incubator at Oslo Research Park. The name comes from AFFInity TECHnology and reflects a focus on developing drugs that have affinity for specific cell types, in particular cancers. The drug ...